Accordingly, we observed that expression of TAAP1 leads to transcriptome alterations correlating with worse prognosis in lung cancer and conversely that knockout of C22orf46 results in beneficial transcriptional changes associated with a better prognosis. This evidence concerns the gene C22orf46P and lung cancer.